Elocta 1500 IU powder and solvent for injectable solution

Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
Evaluation of symptoms and guidance on further diagnostic testing
Preventive check-ups and regular health monitoring
Medical support during travel or after relocation
Treatment adjustments and lifestyle recommendations based on your personal history

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Abdullah Alhasan

Dr. Alhasan’s approach is based on thorough assessment, clear communication, and personalised care – helping patients understand their health and make informed decisions about their treatment.

Dr. Abdullah Alhasan is a physician specialising in cardiology and general medicine, with international clinical experience and a commitment to evidence-based care. He offers online consultations for adults, focusing on both acute symptoms and long-term health management.

Main areas of consultation:

Chest pain, shortness of breath, heart palpitations, high blood pressure
Hypertension control and cardiovascular disease prevention
Interpretation of ECG, blood tests, and Holter monitor results
Management of heart failure and coronary artery disease
General medical issues: infections, fever, fatigue, gastrointestinal symptoms
Guidance on diagnostics, treatment plans, and medication adjustments

Tarek Agami

Main areas of consultation:

Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
Evaluation of symptoms and guidance on further diagnostic testing
Preventive check-ups and regular health monitoring
Medical support during travel or after relocation
Treatment adjustments and lifestyle recommendations based on your personal history

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Abdullah Alhasan

Dr. Alhasan’s approach is based on thorough assessment, clear communication, and personalised care – helping patients understand their health and make informed decisions about their treatment.

Main areas of consultation:

Chest pain, shortness of breath, heart palpitations, high blood pressure
Hypertension control and cardiovascular disease prevention
Interpretation of ECG, blood tests, and Holter monitor results
Management of heart failure and coronary artery disease
General medical issues: infections, fever, fatigue, gastrointestinal symptoms
Guidance on diagnostics, treatment plans, and medication adjustments

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use Elocta 1500 IU powder and solvent for injectable solution

Introduction

Package Leaflet: Information for the User

ELOCTA 250 UI powder and solvent for solution for injection

ELOCTA 500 UI powder and solvent for solution for injection

ELOCTA 750 UI powder and solvent for solution for injection

ELOCTA 1000 UI powder and solvent for solution for injection

ELOCTA 1500 UI powder and solvent for solution for injection

ELOCTA 2000 UI powder and solvent for solution for injection

ELOCTA 3000 UI powder and solvent for solution for injection

ELOCTA 4000 UI powder and solvent for solution for injection

efmoroctocog alfa (recombinant coagulation factor VIII)

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Keep this leaflet, you may need to read it again.
If you have any further questions, ask your doctor, pharmacist, or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

What is ELOCTA and what is it used for
What you need to know before you use ELOCTA
How to use ELOCTA
Possible side effects
Storage of ELOCTA
Contents of the pack and other information

1. What is ELOCTA and what is it used for

ELOCTA contains the active substance efmoroctocog alfa, a recombinant coagulation factor VIII, Fc fusion protein. Factor VIII is a protein that is naturally produced by the body and is necessary for blood to clot and stop bleeding. ELOCTA is a medicine used to treat and prevent bleeding in patients of all ages with hemophilia A (a bleeding disorder caused by a lack of factor VIII).

ELOCTA is prepared using recombinant technology without the addition of any human or animal components in the manufacturing process.

How ELOCTA works

In patients with hemophilia A, factor VIII is missing or does not work properly. ELOCTA is used to replace the missing or defective factor VIII. ELOCTA increases the levels of factor VIII in the blood and temporarily corrects the tendency to bleed.

2. What you need to know before you use ELOCTA

Do not use ELOCTA:

if you are allergic to efmoroctocog alfa or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start using ELOCTA.

There is a small chance that you may have an allergic reaction (anaphylactic reaction) to ELOCTA. Signs of allergic reactions include itching all over the body, hives, feeling of tightness in the chest, difficulty breathing, and low blood pressure. If you get any of these symptoms, stop the injection immediately and contact your doctor.

The formation of inhibitors (antibodies) is a known complication that can occur during treatment with all factor VIII medicines. These inhibitors, especially in large amounts, can prevent the treatment from working properly, so you and your child will be carefully monitored for the development of these inhibitors. If your bleeding or your child's bleeding is not being controlled with ELOCTA, contact your doctor immediately.

Cardiovascular events

If you have heart disease or are at risk of heart disease, be careful when using factor VIII medicines and talk to your doctor.

Catheter-related complications

If you need a central venous access device (CVAD), consider the risk of CVAD-related complications, including local infections, bacteria in the blood, and thrombosis at the catheter insertion site.

Documentation

We strongly recommend that each time ELOCTA is administered, the product name and batch number are recorded.

Other medicines and ELOCTA

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Driving and using machines

No effects on the ability to drive or use machines have been observed.

ELOCTA contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per vial; this is essentially "sodium-free".

However, depending on your body weight and dose, you may receive more than one vial, which should be taken into account if you are on a low-sodium diet.

3. How to use ELOCTA

Treatment with ELOCTA will be started by a doctor who is experienced in the care of patients with hemophilia. Follow the instructions for administration of this medicine exactly as your doctor has told you (see section Instructions for preparation and administration). If you are unsure, talk to your doctor, pharmacist, or nurse.

ELOCTA is given by injection into a vein. Your doctor will calculate your dose of ELOCTA (in International Units or "IU"), depending on your individual needs for factor VIII replacement therapy and whether it is used for prevention or treatment of bleeding. Talk to your doctor if you think you are not getting control of your bleeding with the dose you are getting.

How often you need an injection will depend on how well ELOCTA is working for you. Your doctor will do the necessary laboratory tests to make sure you have adequate levels of factor VIII in your blood.

Treatment of bleeding

The dose of ELOCTA is calculated based on your body weight and the desired factor VIII levels. The target factor VIII levels depend on the severity and location of the bleeding.

Prevention of bleeding

The usual dose of ELOCTA is 50 IU per kilogram of body weight, given every 3 to 5 days. Your doctor may adjust the dose within the range of 25 to 65 IU per kilogram of body weight. In some cases, especially in younger patients, shorter dosing intervals or higher doses may be needed.

Use in children and adolescents

ELOCTA can be used in children and adolescents of all ages. In children under 12 years of age, higher doses or more frequent injections may be needed.

If you use more ELOCTA than you should

Tell your doctor as soon as possible. Follow the instructions for administration of ELOCTA exactly as your doctor has told you. If you are unsure, talk to your doctor, pharmacist, or nurse.

If you forget to use ELOCTA

Do not take a double dose to make up for forgotten doses. Take your dose as soon as you remember and then continue with your normal dosing schedule. If you are not sure what to do, talk to your doctor or pharmacist.

If you stop using ELOCTA

Do not stop using ELOCTA without talking to your doctor. If you stop using ELOCTA, you may no longer be protected against bleeding or a bleeding that is already present may not stop.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If a severe and sudden allergic reaction (anaphylactic reaction) occurs, the injection should be stopped immediately. Contact your doctor immediately if you get any of the following symptoms of allergic reactions: swelling of the face, rash, itching all over the body, hives, feeling of tightness in the chest, difficulty breathing, and low blood pressure.

In previously untreated children with factor VIII medicines (see section 2), inhibitors (antibodies) may occur very frequently (more than 1 in 10 patients); however, in patients who have received prior treatment with factor VIII (more than 150 days of treatment), the risk is uncommon (less than 1 in 100 patients). If this happens, the medicines may stop working properly and you may have persistent bleeding. In this case, contact your doctor immediately.

The following side effects may occur with this medicine.

Uncommon side effects (may affect up to 1 in 100 people)

Headache, dizziness, taste disturbances, slow heart rate, high blood pressure, flushing, vascular pain after injection, cough, lower abdominal pain, skin rash, papular rash, device-related thrombosis, joint swelling, muscle pain, back pain, joint pain, general malaise, chest pain, feeling of cold, feeling of heat, and low blood pressure.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of ELOCTA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after "EXP". The expiry date refers to the last day of the month shown.

Do not use this medicine if it has been stored at room temperature for more than 6 months.

Store in a refrigerator (2°C - 8°C).

Do not freeze.

Store in the original package to protect from light.

Alternatively, ELOCTA can be stored at room temperature (up to 30°C) for a single period not exceeding 6 months. Record the date when ELOCTA is removed from the refrigerator and stored at room temperature on the carton. After storage at room temperature, the medicine should not be returned to the refrigerator.

Once you have prepared ELOCTA, you must use it immediately. If you cannot use the prepared ELOCTA solution immediately, you must use it within 6 hours. Do not refrigerate the prepared solution. Protect the prepared solution from direct sunlight.

The prepared solution should be clear to slightly opalescent and colorless. Do not use this medicine if you notice it is cloudy or contains visible particles.

Dispose of any unused solution properly. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

ELOCTA Composition

The active ingredient is efmoroctocog alfa (recombinant coagulation factor VIII, Fc fusion protein). Each vial of ELOCTA nominally contains 250, 500, 750, 1,000, 1,500, 2,000, 3,000, or 4,000 IU of efmoroctocog alfa.

The other components are sucrose, sodium chloride, L-histidine, calcium chloride dihydrate, polysorbate 20, sodium hydroxide, hydrochloric acid, and water for injectable preparations. See section 2 if you are on a low-sodium diet.

Product Appearance and Container Contents

ELOCTA is presented as a powder and solvent for solution for injection. The powder is a white to off-white powder or cake. The solvent supplied for the preparation of the solution for injection is a clear and colorless solution. After preparation, the solution for injection is clear to slightly opalescent and colorless.

Each ELOCTA container contains 1 vial of powder, 3 mL of solvent in a prefilled syringe, 1 plunger rod, 1 vial adapter, 1 infusion set, 2 alcohol swabs, 2 band-aids, and 1 gauze.

Marketing Authorization Holder and Manufacturer

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm,

Sweden

Date of Last Revision of this Leaflet: 01/2021

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Turn the leaflet over to read the preparation and administration instructions

Preparation and Administration Instructions

ELOCTA is administered by intravenous (IV) injection after dissolving the injectable powder with the solvent supplied in the prefilled syringe. The ELOCTA container contains:

Vial with powder, prefilled syringe, plunger rod, adapter, infusion set, alcohol swabs, band-aids, and gauze

ELOCTA must not be mixed with other injectable solutions or infusion solutions.

Wash your hands before opening the container.

Preparation:

Check the name and dose of the medication on the container to ensure it contains the correct medication. Check the expiration date on the ELOCTA carton. Do not use the medication if it is expired.

If ELOCTA has been stored in the refrigerator, allow the ELOCTA vial (A) and the solvent syringe (B) to reach room temperature before use. Do not use external heat.

Place the vial on a clean and flat surface. Remove the plastic closure cap from the ELOCTA vial.

Clean the top of the vial with one of the alcohol swabs (F) provided in the container and let it air dry. Do not touch the top of the vial or allow it to come into contact with anything once cleaned.

Remove the paper cover from the plastic vial adapter (D). Do not remove the adapter from its protective cap. Do not touch the inside of the vial adapter container.

Hold the vial adapter in its protective cap and place it directly over the top of the vial. Press firmly downward until the adapter is fully engaged with the top of the vial, with the adapter's spike penetrating the vial's stopper.

Attach the plunger rod (C) to the solvent syringe by inserting the tip of the plunger rod into the syringe's plunger opening. Turn the plunger rod clockwise until it is fully seated on the syringe's plunger.

Remove the tamper-evident plastic cap from the solvent syringe by bending it at the puncture cap until it breaks. Set the cap aside with the top facing down on a flat surface. Do not touch the inside of the cap or the tip of the syringe.

Remove the protective cap from the vial adapter by lifting it and discarding it.

Connect the solvent syringe to the vial adapter by inserting the tip of the syringe into the adapter's opening. Push firmly and turn the syringe clockwise until it is fully connected.

Slowly press the plunger rod downward to inject all of the solvent into the ELOCTA vial.

With the syringe still connected to the adapter and the plunger rod pressed downward, gently swirl the vial in a circular motion until the powder is dissolved.

Do not shake. Auto-injector device with a connected vial showing curved arrows indicating rotation for connection

The final solution should be inspected visually before administration. The solution should be clear to slightly opalescent and colorless. Do not use the solution if it is cloudy or contains visible particles.

Ensuring the syringe's plunger rod is still fully pressed downward, invert the vial. Slowly pull the plunger rod to transfer all of the solution into the syringe through the vial adapter.

Disconnect the syringe from the vial adapter by gently pulling the vial while turning it counterclockwise.

Note: If using more than one ELOCTA vial per injection, each vial must be prepared separately according to the previous instructions (steps 1 to 13) and the solvent syringe must be removed, leaving the vial adapter in place. A single larger luer lock syringe can be used to withdraw the prepared contents from each of the vials.

Discard the vial and adapter.

Note: If the solution is not to be used immediately, the syringe cap should be carefully replaced over the tip of the syringe. Do not touch the tip of the syringe or the inside of the cap.

After preparation, ELOCTA can be stored at room temperature for a maximum of 6 hours before administration. After this time, the prepared ELOCTA solution must be discarded. Protect it from direct sunlight.

Administration (Intravenous Injection):

ELOCTA should be administered using the infusion set (E) provided in the container.

Open the infusion set container and remove the cap from the end of the tube. Attach the syringe with the prepared ELOCTA solution to the end of the tube of the infusion set by turning it clockwise.

Hand holding an infusion device with a transparent connector and a thin tube connected to a catheter

If necessary, apply a tourniquet and prepare the injection site by cleaning the skin well with the other alcohol swab provided in the container.

Hand applying an adhesive patch to the skin of the arm in two sequential steps showing the removal of the protector

Remove all air from the infusion set tube by slowly pressing the plunger rod downward until the liquid has reached the needle of the infusion set. Do not push the solution through the needle. Remove the transparent plastic protector from the needle.

Insert the infusion set needle into a vein, as instructed by your doctor or nurse, and remove the tourniquet. If preferred, you can use one of the band-aids (G) provided in the container to secure the plastic wings of the needle in place at the injection site. The prepared product should be injected intravenously over several minutes. Your doctor may adjust the recommended injection rate to make it more comfortable for you.

Once the injection is complete and the needle is removed, the needle protector should be folded back and locked over the needle.

Hand holding an auto-injectable injection device with an arrow indicating the direction of insertion

Discard the used needle, any unused solution, the syringe, and the empty vial in an appropriate medical waste container, as these materials may cause harm to others if not disposed of properly. Do not reuse the equipment.

Country of registration
Spain
Active substance
coagulation factor VIII
Prescription required
Yes
Manufacturer
Swedish Orphan Biovitrum Ab (Publ)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Alternatives to Elocta 1500 IU powder and solvent for injectable solution
ADVATE 1,000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1,000 IU
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required
ADVATE 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1500 IU
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required
ADVATE 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1000 IU - after reconstitution in 2 ml of water for injections, the dose is 500 IU/ml
Active substance: coagulation factor VIII
Manufacturer: Takeda Manufacturing Austria Ag
Prescription required

Alternatives to Elocta 1500 IU powder and solvent for injectable solution in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to Elocta 1500 IU powder and solvent for injectable solution in Poland

Pharmavate

Dosage form: Powder, 50 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Octapharma AB Octapharma Pharmazeutika Produktionsges.m.g.H. Octapharma S.A.S.

Prescription required

Pharmavate

Dosage form: Powder, 100 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Octapharma AB Octapharma Pharmazeutika Produktionsges.m.g.H. Octapharma S.A.S.

Prescription required

Beriate 2000

Dosage form: Powder, 2000 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 1000

Dosage form: Powder, 1000 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 500

Dosage form: Powder, 500 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Beriate 250

Dosage form: Powder, 250 IU

Active substance: coagulation factor VIII

Manufacturer: CSL Behring GmbH

Prescription required

Alternative to Elocta 1500 IU powder and solvent for injectable solution in Ukraine

Dosage form: lyophilizate, 500 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

Dosage form: lyophilizate, 3000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

Dosage form: lyophilizate, 250 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

Dosage form: lyophilizate, 2000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

Dosage form: lyophilizate, 1000 IU

Active substance: coagulation factor VIII

Manufacturer: Vaet Farma S.A.

Prescription required

OKTANAT

Dosage form: powder, 50 IU/ml

Active substance: coagulation factor VIII

Manufacturer: Oktafarma AB (virobnictvo za povnim ciklom za viklucennam vtorinnoi upakovki)

Prescription required

Online doctors for Elocta 1500 IU powder and solvent for injectable solution

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Elocta 1500 IU powder and solvent for injectable solution – subject to medical assessment and local rules.

0.0(0)

Tarek Agami

Main areas of consultation:

Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
Evaluation of symptoms and guidance on further diagnostic testing
Preventive check-ups and regular health monitoring
Medical support during travel or after relocation
Treatment adjustments and lifestyle recommendations based on your personal history

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Abdullah Alhasan

Dr. Alhasan’s approach is based on thorough assessment, clear communication, and personalised care – helping patients understand their health and make informed decisions about their treatment.

Main areas of consultation:

Chest pain, shortness of breath, heart palpitations, high blood pressure
Hypertension control and cardiovascular disease prevention
Interpretation of ECG, blood tests, and Holter monitor results
Management of heart failure and coronary artery disease
General medical issues: infections, fever, fatigue, gastrointestinal symptoms
Guidance on diagnostics, treatment plans, and medication adjustments

Family medicine17 years of experience

Nuno Tavares Lopes

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC. He offers online consultations in Portuguese, English, and Spanish — combining global expertise with a patient-centred, evidence-based approach.

Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
Family medicine: hypertension, diabetes, cholesterol, chronic disease management
Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
Weight management and wellness: personalised weight loss programmes, lifestyle guidance
Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
Pain management: acute and chronic pain, post-surgical care
Public health: prevention, health screenings, long-term monitoring
Sick leave (Baixa médica) connected to Segurança Social in Portugal
IMT medical certificates for driving licence exchange

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Family medicine4 years of experience

Duarte Meneses

Dr. Duarte Meneses is a licensed family medicine and general practice doctor based in Portugal, with additional expertise in occupational health. He provides online consultations for adults, offering medical support for both acute symptoms and chronic health conditions.

Common symptoms such as fever, sore throat, cough, fatigue, or digestive issues
Chronic conditions including hypertension, diabetes, high cholesterol, and thyroid problems
Mental health concerns such as stress, sleep issues, anxiety, and burnout
Preventive care: health check-ups, lifestyle advice, and follow-up for existing conditions
Work-related health questions, sick leave documentation, and medical guidance for returning to work

Dr. Meneses graduated from the University of Beira Interior and has years of experience working with diverse patient populations. He is fluent in Portuguese, English, Spanish, and French.

His approach is friendly, clear, and focused on delivering practical medical advice tailored to each patient’s needs.

General medicine5 years of experience

Ngozi Precious Okwuosa

Dr. Ngozi Precious Okwuosa is a Primary Care Physician with over 5 years of clinical experience in Hungary, Sweden, and Nigeria. A graduate of the University of Szeged (cum laude), she offers online consultations for adults in the areas of internal medicine, women’s health, and postoperative care.

Key areas of consultation:

Preventive and family medicine
Women’s health, including gynaecology and obstetrics
Chronic disease management: hypertension, diabetes, and more
Mental health support, anxiety, and counselling
Postoperative care and lab test interpretation

She has conducted research on the genetic background of stroke and is skilled in communicating with patients from diverse cultural backgrounds. Her approach combines clinical expertise with empathy and clear communication.

General medicine6 years of experience

Andrei Popov

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including:

Chronic pain lasting more than 3 months.
Migraines and recurring headaches.
Neck, back, lower back, and joint pain.
Post-traumatic pain following injury or surgery.
Nerve-related pain, fibromyalgia, and neuralgia.

In addition to pain management, Dr. Popov helps patients with:

Respiratory infections (colds, bronchitis, pneumonia).
High blood pressure and metabolic conditions such as diabetes.
Preventive care and routine health check-ups.

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

General medicine7 years of experience

Sergio Correa

Dr. Sergio Correa is a licensed general practitioner, aesthetic medicine specialist, and trichologist with experience in emergency care and preventive health. He offers online consultations in English and Spanish, supporting adult patients with a wide range of medical concerns – from acute symptoms to chronic condition management.

His areas of focus include:

General and urgent care: fever, fatigue, infections, digestive issues, respiratory symptoms, and other common concerns
Chronic condition support: hypertension, high cholesterol, diabetes, thyroid issues
Aesthetic medicine and dermatology: acne, skin ageing, hyperpigmentation, personalised skincare guidance
Trichology: hair loss, scalp conditions, treatment strategies for men and women
Preventive care: health check-ups, lifestyle advice, second opinions

Dr. Correa combines medical knowledge with an aesthetic and holistic approach to help patients improve both health and quality of life.

General medicine20 years of experience

Hocine Lokchiri

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

fever, chills, fatigue and viral symptoms
cough, sore throat, nasal congestion, breathing discomfort
bronchitis and mild asthma flare-ups
nausea, diarrhoea, abdominal pain, digestive infections
rashes, allergic reactions, redness, insect bites
muscle or joint pain, mild injuries, sprains
headache, dizziness, migraine symptoms
stress-related symptoms, sleep disturbances
questions about test results and treatment plans
management of chronic conditions in stable phases

Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

Advanced Trauma Life Support (ATLS)
Basic and Advanced Cardiac Life Support (BLS/ACLS)
Pediatric Advanced Life Support (PALS)
Prehospital Trauma Life Support (PHTLS)
eFAST and critical care transthoracic echocardiography
aviation medicine

He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.

General medicine29 years of experience

Tetiana Fedoryshyn

Dr Tetiana Fedoryshyn is a senior general practitioner, certified nutritionist, and psychologist with over 29 years of clinical experience. She combines classical internal medicine with modern approaches in lifestyle medicine, functional nutrition, and emotional health support.

Her focus is on helping patients regain health through deep understanding of symptoms, personalised nutrition plans, and evidence-based correction of deficiencies, stress-related conditions, and metabolic imbalances. Dr Fedoryshyn works with adults experiencing chronic conditions, fatigue, hormonal disruption, and post-stress exhaustion.

She integrates medical analysis, psychological insight, and real-life behaviour change tools to offer treatment plans tailored to each patient’s biochemistry, mental state, and lifestyle.

Main areas of practice:

Chronic condition management and medical counselling
Weight loss programmes based on metabolic profiling
Diagnosis and treatment of micronutrient deficiencies
Recovery from stress, burnout, and hormonal imbalances
Emotional support and psychosomatic symptom care

Her approach is never one-size-fits-all – each consultation begins with a deep dive into your unique health history, test results, and emotional landscape. Consultations are available in Ukrainian, Polish, and Russian.

General surgery11 years of experience

Yevgen Yakovenko

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

12+ years of clinical experience in university hospitals in Germany and Spain.
International education: Ukraine – Germany – Spain.
Member of the German Society of Surgeons (BDC).
Certified in radiological diagnostics and robotic surgery.
Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.